4/8
08:03 am
nrsn
NeuroSense Therapeutics (NRSN) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $14.00 price target on the stock.
Low
Report
NeuroSense Therapeutics (NRSN) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $14.00 price target on the stock.
4/6
09:42 am
nrsn
NeuroSense Granted Brazilian Patent Covering PrimeC Composition [Yahoo! Finance]
High
Report
NeuroSense Granted Brazilian Patent Covering PrimeC Composition [Yahoo! Finance]
4/6
09:20 am
nrsn
NeuroSense Granted Brazilian Patent Covering PrimeC Composition
Medium
Report
NeuroSense Granted Brazilian Patent Covering PrimeC Composition
4/3
10:50 am
nrsn
NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements [Yahoo! Finance]
Medium
Report
NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements [Yahoo! Finance]
4/3
10:02 am
nrsn
NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements
Medium
Report
NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements
3/31
09:57 am
nrsn
NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update [Yahoo! Finance]
3/31
09:30 am
nrsn
NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update [TheStreet.com]
Medium
Report
NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update [TheStreet.com]
3/31
09:20 am
nrsn
NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update
Medium
Report
NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update
4/6
09:20 am
nrsn
Form 6-K NeuroSense Therapeutics For: Apr 06
Medium
Report
Form 6-K NeuroSense Therapeutics For: Apr 06
4/3
09:27 am
nrsn
Form 6-K NeuroSense Therapeutics For: Apr 03
Medium
Report
Form 6-K NeuroSense Therapeutics For: Apr 03
4/1
04:26 pm
nrsn
Form 4 NeuroSense Therapeutics For: Mar 26 Filed by: Eisenberg Or
Medium
Report
Form 4 NeuroSense Therapeutics For: Mar 26 Filed by: Eisenberg Or
4/1
04:25 pm
nrsn
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Eisenberg Or
Medium
Report
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Eisenberg Or
3/31
04:17 pm
nrsn
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Mandil-Levin Revital
Low
Report
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Mandil-Levin Revital
3/31
09:30 am
nrsn
Form 20-F NeuroSense Therapeutics For: Dec 31
Medium
Report
Form 20-F NeuroSense Therapeutics For: Dec 31
3/31
09:30 am
nrsn
Form 6-K NeuroSense Therapeutics For: Mar 31
Medium
Report
Form 6-K NeuroSense Therapeutics For: Mar 31
3/30
05:35 pm
nrsn
Form 4 NeuroSense Therapeutics For: Mar 26 Filed by: Russek-Blum Niva
Medium
Report
Form 4 NeuroSense Therapeutics For: Mar 26 Filed by: Russek-Blum Niva
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register